​Meet UBC’s investor ready companies at Innovation UBC's 2026 Investor Showcase!

​What is it 

​The Investor Showcase spotlights high-potential ventures at UBC raising Seed to Series A rounds. A must-attend event for anyone wanting to connect with founders and the next generation of companies shaping their sectors.

​Meet the teams presenting

​Twelve UBC ventures will be taking the stage at Innovation UBC's 2026 Investor Showcase. This year's teams span four broad areas: health and digital therapeutics, medical devices and diagnostics, AI and deep tech, and clean materials and biotech. Together, they represent the breadth and quality of research translation emerging from UBC's Faculties of Applied Science, Medicine, Science, and Land and Food Systems.

Learn more about the ventures.

​How it works

​The event will feature a diverse selection of ventures across industries, chosen by an external evaluation committee.

​Presenting teams are from our community of ventures currently supported by Innovation UBC’s Venture Founder program and HATCH Venture Builder (HATCH), our collaboration with the Institute for Computing, Information and Cognitive Systems (ICICS). 

​Interested investors can learn more about the ventures by registering for the event to receive detailed information on who is pitching in advance. 

​Agenda

• ​4:00 pm Networking

• ​5:00 pm Show begins

• ​6:00 pm Break for networking

• ​6:30 pm Second round of pitches

• ​7:45 pm Closing Remarks

​About Innovation UBC

​Innovation UBC is a service-oriented unit dedicated to enabling UBC researchers and students to translate their work into societal and economic impact.

​Innovation UBC works with UBC’s researchers to support and accelerate the translation of their research into real world impacts. Through research partnerships, technology transfer, and venture building services, UBC researchers have access to a robust ecosystem of services and support to strengthen their translation opportunities. Our successful history of translation and commercialization has led to the creation of 284 spin-off companies, establishing over 500 active licensing agreements, and enabling thousands of research partnerships each year with industry, government, and non-profit organizations. We support $190M+ annually in sponsored research activities (which is more than 80% of provincial sponsored research funding). UBC licensed technologies have attracted over $8.4 billion in investment capital and generated over $13 billion in revenues. 91% of UBC spin-off companies remain in Canada, 88% in BC.

​Our mission is to help create impact from UBC’s breakthrough research to generate social, health, environmental and economic benefits.